RxDoctor Payments Data

Richard Olson, MD

Family Medicine · Lakin, KSNPI 1619263175

Payments from drug & device makers

$447in general payments, 2019–2025

Across 30 payments — averaging $14.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$147
  • AstraZeneca$101
  • AbbVie$56
  • Sanofi-aventis U.S. LLC$36
  • Amgen$17
  • Mylan Specialty L.p.$15
  • plus $74 from 5 others

What the payments were for

  • Food & beverage$447100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$447 in reported general payments places this provider in the 45th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$8,927
Medicare patients
34
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide99$95,817
JardianceEmpagliflozin112$92,136
Tresiba Flextouch U-200Insulin Degludec61$39,974
TrulicityDulaglutide32$34,305
MounjaroTirzepatide26$28,613
Tresiba Flextouch U-100Insulin Degludec68$26,825
EliquisApixaban64$20,994
XareltoRivaroxaban35$18,403
LinzessLinaclotide23$17,362
InvokanaCanagliflozin15$12,232
MyrbetriqMirabegron25$11,771
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$10,888
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$10,255
SteglatroErtugliflozin Pidolate14$9,245
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,813

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$147$95,81799 claims
Lilly USA, LLCTrulicity, Mounjaro$15$62,91858 claims
AstraZenecaBreztri Aerosphere, Bevespi Aerosphere, Farxiga, Symbicort$101$26,53257 claims
PfizerEliquis$15$20,99464 claims
AbbVieLinzess$56$17,36223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Lakin

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →